Diant Pharma Inc. — Form D
Diant Pharma Inc. of MANCHESTER, CT, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-30. The offering totals $4.8M, of which $1.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-30
- Form: D
- Accession: 0001949139-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.8M
- Amount sold: $1.4M
- Remaining: $3.4M
- Investors: 4
- Date of first sale: 2022-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460456
Issuer
- Name: Diant Pharma Inc.
- CIK: 0001949139
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 130 UTOPIA RD. STE 12, MANCHESTER, CT, 06042
- Phone: 774-462-2227
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Diane Burgess | Director | MANCHESTER, CT |
| Antonio Costa | Director | MANCHESTER, CT |
| Diane Burgess | Executive Officer | MANCHESTER, CT |
| Antonio Costa | Executive Officer | MANCHESTER, CT |
More